{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:47:30Z","timestamp":1793767650104,"version":"4.6.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.trre.2024.100878","type":"journal-article","created":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T11:51:55Z","timestamp":1725709915000},"page":"100878","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Factors and interventions affecting tacrolimus intrapatient variability: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"38","author":[{"given":"Hongsheng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongsheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2024.100878_bb0005","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/phar.2480","article-title":"Tacrolimus intrapatient variability in solid organ transplantation: a multiorgan perspective","volume":"41","author":"Schumacher","year":"2021","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.trre.2024.100878_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.trre.2024.100842","article-title":"Tacrolimus intra-patient variability measures and its associations with allograft clinical outcomes in kidney transplantation","volume":"38","author":"Xie","year":"2024","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.trre.2024.100878_bb0015","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1159\/000503167","article-title":"The epidemiologic burden of tacrolimus variability among kidney transplant recipients in the United States","volume":"50","author":"Shah","year":"2019","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.trre.2024.100878_bb0020","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.trre.2024.100878_bb0025","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.trre.2024.100878_bb0030","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.trre.2024.100878_bb0035","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (minors): development and validation of a new instrument","volume":"73","author":"Slim","year":"2003","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.trre.2024.100878_bb0040","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.trre.2024.100878_bb0045","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.transproceed.2019.04.019","article-title":"Impact of CYP3A5 genetic polymorphism on intrapatient variability of tacrolimus exposure in Chinese kidney transplant recipients","volume":"51","author":"Cheung","year":"2019","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2024.100878_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11216320","article-title":"Comparison of tacrolimus intra-patient variability during 6-12 months after kidney transplantation between CYP3A5 expressers and nonexpressers","volume":"11","author":"Nuchjumroon","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.trre.2024.100878_bb0055","doi-asserted-by":"crossref","first-page":"159","DOI":"10.7196\/SAMJ.2020.v110i2.13969","article-title":"CYP3A5 polymorphisms and their effects on tacrolimus exposure in an ethnically diverse South African renal transplant population","volume":"110","author":"Muller","year":"2020","journal-title":"S Afr Med J"},{"key":"10.1016\/j.trre.2024.100878_bb0060","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/FTD.0b013e31821a7aa3","article-title":"CYP3A5 genotype is not related to the intrapatient variability of tacrolimus clearance","volume":"33","author":"Pashaee","year":"2011","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.trre.2024.100878_bb0065","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/FTD.0b013e318289644d","article-title":"CYP3A5 genotype had no impact on intrapatient variability of tacrolimus clearance in renal transplant recipients","volume":"35","author":"Spierings","year":"2013","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.trre.2024.100878_bb0070","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.transproceed.2013.11.084","article-title":"Reduced variability of tacrolimus trough level in once-daily tacrolimus-based Taiwanese kidney transplant recipients with high-expressive genotype of cytochrome P450 3A5","volume":"46","author":"Wu","year":"2014","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2024.100878_bb0075","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/01.TP.0000437561.31212.0e","article-title":"Lower variability in 24-hour exposure during once-daily compared to twice-daily tacrolimus formulation in kidney transplantation","volume":"97","author":"Stifft","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2024.100878_bb0080","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/cts.13206","article-title":"A randomized crossover study comparing different tacrolimus formulations to reduce intrapatient variability in tacrolimus exposure in kidney transplant recipients","volume":"15","author":"Bunthof","year":"2022","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.trre.2024.100878_bb0085","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/FTD.0b013e3182731809","article-title":"Impact of tacrolimus intraindividual variability and CYP3A5 genetic polymorphism on acute rejection in kidney transplantation","volume":"34","author":"Ro","year":"2012","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.trre.2024.100878_bb0090","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13424","article-title":"Tacrolimus trough and dose intra-patient variability and CYP3A5 genotype: effects on acute rejection and graft failure in European American and African American kidney transplant recipients","volume":"32","author":"Seibert","year":"2018","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2024.100878_bb0095","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/tri.13412","article-title":"Evaluation of tools for annual capture of adherence to immunosuppressive medications after renal transplantation - a single-centre open prospective trial","volume":"32","author":"Gustavsen","year":"2019","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2024.100878_bb0100","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12882-020-01781-1","article-title":"Accuracy and concordance of measurement methods to assess non-adherence after renal transplantation - a prospective study","volume":"21","author":"Lieb","year":"2020","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.trre.2024.100878_bb0105","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/FTD.0000000000000772","article-title":"No apparent influence of nonadherence on tacrolimus intrapatient variability in stable kidney transplant recipients","volume":"42","author":"Gokoel","year":"2020","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.trre.2024.100878_bb0110","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s10620-012-2412-0","article-title":"Non-adherence and graft failure in adult liver transplant recipients","volume":"58","author":"Lieber","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.trre.2024.100878_bb0115","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/675301","article-title":"Attitudes to medication after kidney transplantation and their association with medication adherence and graft survival: a 2-year follow-up study","volume":"2014","author":"Tielen","year":"2014","journal-title":"J Transplant"},{"key":"10.1016\/j.trre.2024.100878_bb0120","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1038\/s41598-021-84868-5","article-title":"Association between medication adherence and intrapatient variability in tacrolimus concentration among stable kidney transplant recipients","volume":"11","author":"Ko","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.trre.2024.100878_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.973564","article-title":"Comparison of different methods to assess tacrolimus concentration intra-patient variability as potential marker of medication non-adherence","volume":"13","author":"Kostalova","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.trre.2024.100878_bb0130","doi-asserted-by":"crossref","DOI":"10.1177\/15269248221087440","article-title":"Evaluation of the relationship between medication adherence and tacrolimus coefficient of variation","author":"Leino","year":"2022","journal-title":"Prog Transplant"},{"key":"10.1016\/j.trre.2024.100878_bb0135","doi-asserted-by":"crossref","DOI":"10.1177\/20543581211021742","article-title":"Retrospective analysis of tacrolimus intrapatient variability as a measure of medication adherence","volume":"8","author":"Herblum","year":"2021","journal-title":"Can J Kidney Health Dis"},{"key":"10.1016\/j.trre.2024.100878_bb0140","first-page":"447","article-title":"Prospective randomized trial investigating the influence of pharmaceutical care on the intra-individual variability of tacrolimus concentrations early after kidney transplant","volume":"38","author":"Bessa","year":"2016","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.trre.2024.100878_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13111970","article-title":"Effect of the interrelation between CYP3A5 genotype, concentration\/dose ratio and intrapatient variability of tacrolimus on kidney graft function: Monte Carlo simulation approach","volume":"13","author":"Stefanovi\u0107","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.trre.2024.100878_bb0150","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/15269248221145044","article-title":"Tacrolimus formulation, exposure variability, and outcomes in kidney transplant recipients","volume":"33","author":"Lai","year":"2023","journal-title":"Prog Transplant"},{"key":"10.1016\/j.trre.2024.100878_bb0155","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/FPC.0b013e32833ea085","article-title":"Differential impact of the CYP3A5*1 and CYP3A5*3 alleles on pre-dose concentrations of two tacrolimus formulations","volume":"21","author":"Wehland","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.trre.2024.100878_bb0160","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001465","article-title":"Efficacy of prolonged-release tacrolimus after conversion from immediate-release tacrolimus in kidney transplantation: a retrospective analysis of long-term outcomes from the ADMIRAD study","volume":"9","author":"Kuypers","year":"2023","journal-title":"Transplant Direct"},{"key":"10.1016\/j.trre.2024.100878_bb0165","doi-asserted-by":"crossref","first-page":"313","DOI":"10.6002\/ect.2018.0043","article-title":"Incidence of donor-specific anti-HLA antibodies in non-HLA-sensitized patients given tacrolimus once or twice daily during the first 2 years after kidney transplant","volume":"17","author":"Hage","year":"2019","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.trre.2024.100878_bb0170","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/j.transproceed.2020.02.109","article-title":"Conversion from a twice-daily to a once-daily tacrolimus formulation in kidney transplant recipients","volume":"52","author":"Kami\u0144ska","year":"2020","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2024.100878_bb0175","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1016\/j.transproceed.2011.08.021","article-title":"Tacrolimus dose and blood concentration variability in kidney transplant recipients undergoing conversion from twice daily to once daily modified release tacrolimus","volume":"43","author":"Kurnatowska","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2024.100878_bb0180","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/FTD.0000000000000136","article-title":"Conversion from twice-daily to once-daily tacrolimus does not reduce intrapatient variability in tacrolimus exposure","volume":"37","author":"Shuker","year":"2015","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.trre.2024.100878_bb0185","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.transproceed.2019.12.039","article-title":"Trough level and tacrolimus variability of early converted once-daily tacrolimus: 1-year follow-up study","volume":"52","author":"Sukkha","year":"2020","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2024.100878_bb0190","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/TP.0b013e3182292426","article-title":"Lower variability of tacrolimus trough concentration after conversion from prograf to advagraf in stable kidney transplant recipients","volume":"92","author":"Wu","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2024.100878_bb0195","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000000536","article-title":"Medium-term renal function in a large cohort of stable kidney transplant recipients converted from twice-daily to once-daily tacrolimus","volume":"1","author":"Guirado","year":"2015","journal-title":"Transplant Direct"},{"key":"10.1016\/j.trre.2024.100878_bb0200","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0b013e3182725532","article-title":"Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring","volume":"95","author":"Kuypers","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2024.100878_bb0205","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1016\/j.transproceed.2019.02.065","article-title":"Effect on dosage change and intrapatient variability after conversion from twice-daily to once-daily tacrolimus among thai kidney transplant patients with and without CYP3A4\/5 inhibitors","volume":"51","author":"Larpparisuth","year":"2019","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2024.100878_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9061926","article-title":"Number of regularly prescribed drugs and intrapatient tacrolimus trough levels variability in stable kidney transplant recipients","volume":"9","author":"Giza","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.trre.2024.100878_bb0215","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/fcp.12328","article-title":"Factors associated with the variability of calcineurin inhibitor blood levels in kidney recipients grafted for more than 1 year","volume":"32","author":"Belaiche","year":"2018","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.trre.2024.100878_bb0220","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13311","article-title":"Bioavailability and costs of once-daily and twice-daily tacrolimus formulations in de novo kidney transplantation","volume":"32","author":"Glander","year":"2018","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2024.100878_bb0225","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14941","article-title":"Impact of converting adult kidney transplant recipients with high tacrolimus variability from twice daily immediate release tacrolimus to once daily LCP-tacrolimus","volume":"37","author":"Taber","year":"2023","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2024.100878_bb0230","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.amjsurg.2020.02.027","article-title":"The use of LCP-tacrolimus (envarsus XR) in simultaneous pancreas and kidney (SPK) transplant recipients","volume":"219","author":"Torabi","year":"2020","journal-title":"Am J Surg"},{"key":"10.1016\/j.trre.2024.100878_bb0235","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000000930","article-title":"Identification of antibiotic administration as a potentially novel factor associated with tacrolimus trough variability in kidney transplant recipients: a preliminary study","volume":"5","author":"Zheng","year":"2019","journal-title":"Transplant Direct"},{"key":"10.1016\/j.trre.2024.100878_bb0240","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.transproceed.2020.10.003","article-title":"Impact of protease inhibitor-based antiretroviral therapy on tacrolimus intrapatient variability in HIV-positive kidney transplant recipients","volume":"53","author":"Cooper","year":"2021","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2024.100878_bb0245","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.transproceed.2022.10.001","article-title":"Comparative study of 2 extended-release tacrolimus formulations in kidney transplantation","volume":"54","author":"Cholbi Vives","year":"2022","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2024.100878_bb0250","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/tri.13338","article-title":"The impact of time-varying clinical surrogates on disparities in African-American kidney transplant recipients - a retrospective longitudinal cohort study","volume":"32","author":"Taber","year":"2019","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2024.100878_bb0255","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/ajhp\/zxab157","article-title":"Impact of a pharmacist-led, mHealth-based intervention on tacrolimus trough variability in kidney transplant recipients: a report from the TRANSAFE Rx randomized controlled trial","volume":"78","author":"Fleming","year":"2021","journal-title":"Am J Health-Syst Pharm"},{"key":"10.1016\/j.trre.2024.100878_bb0260","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.transproceed.2018.03.097","article-title":"Intervention of online percent coefficient of variation reporting system reduces the variability of tacrolimus trough concentration in kidney transplant recipients","volume":"50","author":"Cheng","year":"2018","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2024.100878_bb0265","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12911-020-01146-6","article-title":"ICT-based adherence monitoring in kidney transplant recipients: a randomized controlled trial","volume":"20","author":"Jung","year":"2020","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.trre.2024.100878_bb0270","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/1060028020931806","article-title":"Exploratory analysis of the impact of an mHealth medication adherence intervention on tacrolimus trough concentration variability: post hoc results of a randomized controlled trial","volume":"54","author":"McGillicuddy","year":"2020","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.trre.2024.100878_bb0275","doi-asserted-by":"crossref","first-page":"7734","DOI":"10.1038\/s41598-019-44002-y","article-title":"Improving medication adherence in adult kidney transplantation (IMAKT): a pilot randomised controlled trial","volume":"9","author":"Low","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.trre.2024.100878_bb0280","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000448627","article-title":"A pilot randomized controlled trial to promote immunosuppressant adherence in adult kidney transplant recipients","volume":"135","author":"Cukor","year":"2017","journal-title":"Nephron"},{"key":"10.1016\/j.trre.2024.100878_bb0285","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1097\/TP.0000000000000708","article-title":"Improved tacrolimus target concentration achievement using computerized dosing in renal transplant recipients\u2013a prospective, randomized study","volume":"99","author":"St\u00f8rset","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2024.100878_bb0290","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/15269248221107043","article-title":"Evaluation of a standardized tacrolimus therapeutic drug monitoring protocol in stable kidney transplant recipients","volume":"32","author":"Ky","year":"2022","journal-title":"Prog Transplant"},{"key":"10.1016\/j.trre.2024.100878_bb0295","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.kint.2023.06.021","article-title":"A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian prediction","volume":"104","author":"Lloberas","year":"2023","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2024.100878_bb0300","article-title":"A pharmacist-led intervention to improve kidney transplant recipient outcomes and identify patients at risk of highly variable trough tacrolimus levels: a cohort study","author":"Lhermitte","year":"2023","journal-title":"Eur J Hosp Pharm"},{"key":"10.1016\/j.trre.2024.100878_bb0305","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/126251","article-title":"Once-daily tacrolimus extended-release formulation: 1 year after conversion in stable pediatric kidney transplant recipients","volume":"2011","author":"Pape","year":"2011","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.trre.2024.100878_bb0310","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14036","article-title":"Impact of once-daily ER-Tac on trough concentration variability in a stable AYA renal transplant recipient cohort","volume":"25","author":"Chandran","year":"2021","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.trre.2024.100878_bb0315","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1053\/j.ajkd.2017.12.012","article-title":"A randomized trial of a multicomponent intervention to promote medication adherence: the teen adherence in kidney transplant effectiveness of intervention trial (TAKE-IT)","volume":"72","author":"Foster","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2024.100878_bb0320","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1432-2277.2011.01412.x","article-title":"Renal function, efficacy and safety postconversion from twice- to once-daily tacrolimus in stable liver recipients: an open-label multicenter study","volume":"25","author":"Sa\u0144ko-Resmer","year":"2012","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2024.100878_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10020272","article-title":"Reducing the pill burden: immunosuppressant adherence and safety after conversion from a twice-daily (IR-Tac) to a novel once-daily (LCP-Tac) tacrolimus formulation in 161 liver transplant patients","volume":"10","author":"Maurer","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.trre.2024.100878_bb0330","first-page":"533","article-title":"Pretransplant psychosocial risk factors may not predict late nonadherence and graft rejection in adult liver transplant recipients","volume":"16","author":"Lieber","year":"2018","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.trre.2024.100878_bb0335","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/lt.24022","article-title":"Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts","volume":"21","author":"Considine","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2024.100878_bb0340","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1399-3046.2007.00791.x","article-title":"Improving adherence to medications in pediatric liver transplant recipients","volume":"12","author":"Shemesh","year":"2008","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.trre.2024.100878_bb0345","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.healun.2021.02.017","article-title":"Once daily tacrolimus conversion in lung transplantation: a prospective study on safety and medication adherence","volume":"40","author":"Godinas","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2024.100878_bb0350","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/jac5.1797","article-title":"Pharmacist-led dosing reduces tacrolimus intrapatient variability in lung transplant recipients","volume":"6","author":"Yang","year":"2023","journal-title":"J Am Coll Clin Pharm"},{"key":"10.1016\/j.trre.2024.100878_bb0355","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/jac5.1534","article-title":"Impact of a clinical pharmacist in an outpatient heart transplant clinic","volume":"4","author":"Prom","year":"2021","journal-title":"J Am Coll Clin Pharm"},{"key":"10.1016\/j.trre.2024.100878_bb0360","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14590","article-title":"Optimizing medication adherence with home-monitoring - a feasibility study using capillary microsampling and mHealth in solid organ-transplanted adolescents","volume":"27","author":"Kindem","year":"2023","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.trre.2024.100878_bb0365","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.602764","article-title":"Tacrolimus intrapatient variability after switching from immediate or prolonged-release to extended-release formulation, after an organ transplantation","volume":"12","author":"Del Bello","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.trre.2024.100878_bb0370","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/ajt.15199","article-title":"Assessment of tacrolimus intrapatient variability in stable adherent transplant recipients: establishing baseline values","volume":"19","author":"Leino","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2024.100878_bb0375","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.amjsurg.2019.02.018","article-title":"Transplant surgery enters a new era: increasing immunosuppressive medication adherence through mobile apps and smart watches","volume":"218","author":"Levine","year":"2019","journal-title":"Am J Surg"},{"key":"10.1016\/j.trre.2024.100878_bb0380","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/j.ajkd.2016.10.017","article-title":"Automated reminders and physician notification to promote immunosuppression adherence among kidney transplant recipients: a randomized trial","volume":"69","author":"Reese","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2024.100878_bb0385","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2023.1150548","article-title":"Improving adherence to immunosuppression after liver or kidney transplantation in individuals with impairments in personality functioning - a randomized controlled single center feasibility study","volume":"14","author":"Wagner-Skacel","year":"2023","journal-title":"Front Psychol"},{"key":"10.1016\/j.trre.2024.100878_bb0390","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1681\/ASN.2017020216","article-title":"Understanding medication nonadherence after kidney transplant","volume":"28","author":"Nevins","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2024.100878_bb0395","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/TP.0000000000003112","article-title":"From nonadherence to adherence","volume":"104","author":"Kuypers","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2024.100878_bb0400","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14278","article-title":"Adoption of a novel smart mobile-health application technology to track chronic immunosuppression adherence in solid organ transplantation: results of a prospective, observational, multicentre, pilot study","volume":"35","author":"Melilli","year":"2021","journal-title":"Clin Transplant"}],"updated-by":[{"DOI":"10.1016\/j.trre.2024.100881","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000}}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X24000612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X24000612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T03:59:54Z","timestamp":1737604794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X24000612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":80,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0955470X24000612"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2024.100878","relation":{},"ISSN":["0955-470X"],"issn-type":[{"value":"0955-470X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors and interventions affecting tacrolimus intrapatient variability: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Transplantation Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trre.2024.100878","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100878"}}